click below
click below
Normal Size Small Size show me how
BMS 450 Exam 3
ANS, Anti-anxiety, and Anti-psychotic Drugs
Drug Name | Mechanism of Action | Summary |
---|---|---|
Epinephrine | Nonselective α and β agonist | Increases cardiac output Vasoconstrictor Bronchodilator |
Norepinephrine | Nonselective α and β agonist | Increases cardiac output Vasoconstrictor |
Albuterol | Selective β2 agonist | Bronchodilator |
Phenylephrine | Selective α1 agonist | Vasoconstrictor |
Clonidine | Selective α2 agonist | Presynaptic inhibitor Decreases cardiac output and total peripheral resistance |
Phenoxybenzamine | Nonselective α antagonist | Non-competitive Irreversible |
Phentolamine | Nonselective α antagonist | Competitive Reversible |
Propranolol | Nonselective β antagonist | Decreases cardiac output Bronchoconstriction |
Atenolol | Selective β1 antagonist | Decreases cardiac arrhythmias Decreases cardiac output |
Acetylcholine | Endogenous cholinergic agonist | SLUDGE |
Bethanechol | Direct acting cholinergic agonist | Synthetic choline ester SLUDGE Some M3 selectivity (promotes voiding) |
Muscarine | Direct acting cholinergic agonist | Cholinomimetic alkaloid SLUDGE |
Atropine | Cholinergic antagonist | Competitive inhibitor of ACh binding Anti-SLUDGE (decreases salivary and airway secretions) |
Ipratropium | Cholinergic antagonist | Anti-SLUDGE (decreases bronchoconstriction and airway secretions) Administered via inhalation |
Propantheline | Cholinergic antagonist | Anti-SLUDGE Promotes urine retention (decreases detrusor and increases trigone and sphincter contraction) |
Prazosin | Selective α1 antagonist | Vasodilator (decreases total peripheral resistance) |
Carvedilol | Mixed α1 and β antagonist | Vasodilator (decreases total peripheral resistance) Decreases cardiac output |
Aliskiren | Renin inhibitor | Competitive antagonist of renin Prevents conversion of angiotensinogen to angiotensin 1 |
Benazepril | ACE inhibitor | Competitive antagonist of ACE Prevents conversion of angiotensin 1 to angiotensin 2 |
Losartan | Angiotensin receptor antagonist | Competitive antagonist AT1 receptors Blocks hypertensive/vasoconstrictor effects of angiotensin 2 (vasodilator) |
Procainamide | Sodium channel blocker (Class 1A) | Antiarrhythmic Slows conduction velocity Prolongs refectory period |
Lidocaine | Sodium channel blocker (Class 1B) | Antiarrhythmic Keeps sodium channels in inactivated state Decreases automaticity in depolarized cells |
Flecainide | Sodium channel blocker (Class 1C) | Antiarrhythmic Profoundly decreases conduction velocity |
Amiodarone | Potassium channel blocker | Antiarrhythmic Action potential prolonging |
Diltiazem | Calcium channel blocker | Antiarrhythmic Decreases ventricular response to atrial fibrillation |
Verapamil | Calcium channel blocker | Antiarrhythmic Decreases ventricular response to atrial fibrillation |
Digoxin | Limits Na/Ca exchanger function indirectly | Decreases calcium efflux (increases CO) Decreases AV nodal conduction and ventricular response to atrial fibrillation |
Adenosine | Miscellaneous antiarrhythmic | Blocks AV nodal conduction Terminates supraventricular tachycardias involving SA node (atrial fibrillation) |
Dopamine | Selective β1 stimulator | Increases cardiac output (heart rate and contractility) |
Dobutamine | Selective β1 stimulator | Increases cardiac output (heart rate and contractility) |
Milrinone | PDE 3 inhibitor | Increases calcium influx Increases cardiac output (contractility) |
Pimobendan | Calcium sensitizer | Increases cardiac contraction Increases Ca binding to troponin C |
Nifedipine | Calcium channel antagonist | Vasodilator (decrease total peripheral resistance) |
Nitroglycerin | Exogenous NO donor | Venous dilation (decrease preload) |
Sodium Nitroprusside | Exogenous NO donor | Arterial and venous dilation (decreases preload and afterload) |
Sildenafil | Phosphodiesterase type 5 inhibitor | Vasodilation (especially in penile corpus cavernosum) |
Minoxidil | Potassium channel activator | Vasodilation (decreases total peripheral resistance) |
Alprazolam | GABA enhancement | Anti-anxiety agent (anxiolytic) |
Chlordiazepoxide | GABA enhancement | Anti-anxiety agent (anxiolytic) |
Diazepam | GABA enhancement | Anti-anxiety agent (anxiolytic) Sedative Muscle relaxant |
Lorazepam | GABA enhancement | Anti-anxiety agent (anxiolytic) |
Oxazepam | GABA enhancement | Anti-anxiety agent (anxiolytic) |
Triazolam | GABA enhancement | Anti-anxiety agent (anxiolytic) |
Buspirone | 5-HT receptor agonist | Anti-anxiety agent (anxiolytic) |